The Wall Street Journal - 20.09.2019

(lily) #1

B6| Friday, September 20, 2019 THE WALL STREET JOURNAL.**


BUSINESS NEWS


be determined.
The Major League Baseball
team, which is valued at $3.2
billion, according to Forbes,
said last year it was looking to
sell a minority stake in the
franchise.
The Los Angeles Dodgers
declined to comment. Gala-
tioto Sports Partners, which
represented Guggenheim Base-
ball Management in the stake
sale, declined to comment.
Mr. Plummer is the founder

of R.P. Lumber Company Inc.,
a chain of material-supply
stores in Illinois and Missouri.
Mr. Smolinisky is an investor
who began his career in com-
mercial real estate. A Los An-
geles native, he owns the Pali-
sadian-Post newspaper in the
Pacific Palisades neighborhood
of the city, according to a per-
son familiar with the matter.
Messrs. Smolinisky and Plum-
mer couldn’t be reached for
comment.

Bloomberg News reported
Wednesday that the Dodgers
had sold a minority stake.
The Los Angeles Dodgers
were sold in 2012 to an invest-
ment group led by Messrs.
Johnson and Walter, the chief
executive of financial-services
firm Guggenheim Partners, for
about $2.15 billion.
At the time, the figure
broke the record for a sales
price for a U.S. sports fran-
chise, The Wall Street Journal

reported, dwarfing Steve
Ross’s 2009 $1.1 billion pur-
chase of the Miami Dolphins.
The Dodgers have finished
in first place in their division
for seven straight seasons and
have the best record in the
National League this year.
The value of sports fran-
chises has ballooned in recent
years, as TV networks are in-
creasingly willing to pay a pre-
mium for the rights to retrans-
mit their content.

The Los Angeles Dodgers
added Alan Smolinisky and
Robert Plummer to the team’s
ownership group, whose mem-
bers include financial-manage-
ment executive Mark Walter
and basketball legend Magic
Johnson, people familiar with
the matter said.
The size and price of the
stake bought by Messrs. Smo-
linisky and Plummer couldn’t

BYBENJAMINMULLIN

Dodgers Add Two to Ownership Team


Startup Takes Bubble Power to the Seine


URBAN MOBILITY: Paris is testing an electric water taxi dubbed the Bubble, which is still in early development stages. Sweden’s Anders Bringdal, co-founder of the
startup, SeaBubbles, standing onboard a model by the Eiffel Tower on Wednesday.

FRANCOIS MORI/ASSOCIATED PRESS


striking distance of a record.
The slide shows how Al-
tria’s $12.8 billion investment
in Juul Labs Inc.—which the
company touted as a way for it
to tap into a rapidly growing
market while offsetting the
broader decline in traditional
smokers—hasn’t worked out
exactly as it had hoped.
Juul has been hit by a num-
ber of setbacks this year that
have put its future in doubt.
President Trump has said he
plans to ban most vaping fla-
vors because of growing

health concerns; the Federal
Trade Commission is investi-
gating whether Juul used in-
fluencers with large social-me-
dia followings to appeal to
minors; and sales of the com-
pany’s vaporizers were
abruptly halted in China.
Worries about the firm’s
potential merger with rival
Philip Morris International
Inc. have also hurt the stock.
Analysts have raised questions
since the two companies con-
firmed that they were discuss-
ing potentially reuniting, with

Citigroup’s Adam Spielman
saying in a note this month
that a deal might only increase
the combined firm’s reliance
on traditional nicotine prod-
ucts at a time when cigarette
use is declining.
One silver lining: After tak-
ing a hit, Altria’s stock looks
relatively cheap. It is trading
at around 9.1 times its ex-
pected earnings over the next
12 months, well below its five-
year average of 17 times. And
shareholders can expect to
reap relatively hefty divi-

dends, too: Altria offers a divi-
dend yield of around 8.2%, ac-
cording to FactSet, around
four times that of the S&P
500.
Not that it is helping draw
investors back in yet.
The regulatory outlook for
vaping products looks riskier
than initially expected, said
Piper Jaffray analyst Michael
Lavery in a note earlier in
September.
He has lowered his rating
for the stock to “neutral” from
“overweight.”

America’s biggest tobacco
company is being burned by
its investment in e-cigarettes.
Altria Group Inc. shares
have tumbled 19% in 2019 to a
roughly five-year low, with
selling accelerating in recent
weeks after health officials
and politicians stepped up
scrutiny of e-cigarette device
Juul.
That is even as the broader
market has rallied, with the
S&P 500 up 20% and within

BYAKANEOTANI

Altria’s E-Cigarette Bet Becomes Drag on Shares


Insys Therapeutics Inc.
won bankruptcy-court ap-
proval to sell Subsys, the opi-
oid that spawned criminal
racketeering charges against
its top executives, and set off
investigations and lawsuits
that plunged the company into
bankruptcy.
It is believed to be the first
bankruptcy sale of a pharma-
ceutical drug that played a
role in fueling the nationwide
opioid epidemic, said Judge
Kevin Gross of the U.S. Bank-
ruptcy Court in Wilmington,
Del. At a court hearing, he said
he would sign off on a sales
agreement that includes safe-
guards to ward off future mis-
use of Subsys.
The deal terms will keep
Subsys on the market, but how
it is prescribed and to whom
will be closely watched, the
judge said.
Insys is a relatively small
player in the universe of com-
panies accused of profiting
from the opioid crisis, and
Subsys is a niche drug, or it
was supposed to be, said Brian
Edmunds, a lawyer for Mary-
land and other states that
raised concerns about the sale
and asked for restrictions to
be built in.
Lawyers for states have
been active in Insys’s bank-
ruptcy, intent on ensuring it
sets high standards for other
opioid bankruptcies, such as
that of OxyContin maker Pur-
due Pharma LP.
The states dropped their
objections to the Subsys sale
at Thursday’s hearing after
agreements were reached with
the buyer, BTcP Pharma LLC.
“This drug has real impor-
tant uses,” Arik Preis, a lawyer
for the official committee of
Insys’s creditors, said at the
hearing. “With the nationwide
opioid crisis we sometimes
lose the fact that these drugs
have real uses.”
Designed to address break-
through cancer pain, the un-
der-the-tongue formulation of
fentanyl was marketed for off-
label uses.
Under the sale terms, BTcP
Pharma and owner Michael M.
Burke pledged to sell the drug
only to doctors treating cancer
patients and to refrain from
aggressive marketing.
It remains unclear what In-
sys’s creditors will get from
the sale, but estimates of roy-
alties, unsold inventory and
accounts receivable could top
$20 million, according to a
lawyer for the company.
Insys was the first company
in the U.S. opioid supply chain
to file for bankruptcy to cope
with liabilities stemming from
widespread addiction.

BYPEGBRICKLEY

Insys Wins


Approval


For Sale


Of Opioid


CIGAR.com is here to prove how serious we are about earning your
trust and respect. How about five premium cigars for$5? Take 86% off
MSRP and savor some fine, flavorful handmade cigars. You’ll score one
each of Nica Libre, CIGAR.com American Label, Ramón Bueso Genesis,
HC Series Maduro, and Gurkha Class Regent. Each premium blend offers
a unique experience, making it the perfect mix for enthusiasts and
beginners alike. This is a limited time, highly exclusive offer, so act quickly.

*Includes shipping. Purchase may be subject to state or local sales tax where applicable. First-time purchasers
only. One per customer. No sales to anyone under the age of 21. We do not ship to Utah and South Dakota.
For more information see http://www.CIGAR.com/SHIP. Offer expires 10.15.19.
CIGAR.com|1911 Spillman Drive|Dept. #26|Bethlehem, PA 18015

http://www.CIGAR.com/CGSA2002
Enter full web address or search keyword: CGSA2002

Call 800.357.9800Mention CGSA2002
Offer expires 10.15.19

5


$


5


CIGARS


only


No-Drill MudFlaps


©2018 by MacNeil IP LLC

FloorLiner™


New!
Non-Toxic
Feeding
System
PetComfort.com

800.441.6287
International #001.630.769.1500
Free download pdf